Ronald R. Breaker

from Wikipedia, the free encyclopedia

Ronald R. Breaker (* 1964 in Tigerton , Wisconsin ) is an American molecular biologist at Yale University .

Life

Breaker earned a bachelor's degree in biology and chemistry from the University of Wisconsin at Stevens Point in 1987 and a Ph.D. in 1992 from Peter Gilham at Purdue University in West Lafayette, Indiana. in biochemistry . As a postdoctoral fellow , he worked with Gerald Joyce at the Scripps Research Institute in La Jolla , California . Breaker has been at Yale University in New Haven (Connecticut) since 1995 , where he is now (as of 2012) Professor of Molecular , Cellular and Developmental Biology and Professor of Molecular Biophysics . Breaker is also doing research for the Howard Hughes Medical Institute .

Act

With the riboswitch, Breaker discovered a mechanism in which metabolites regulate their own synthesis through direct binding to the mRNA that encodes them . Riboswitches are therefore potential target molecules for novel drugs and could regulate genes that have been introduced into cells using gene therapy .

Breaker succeeded for the first time in the synthesis of an enzymatically effective DNA , a so-called deoxyribozyme - the counterpart of an enzymatically effective RNA is called a ribozyme . Breaker’s further research is concerned with other forms of non-coding RNA and the role of RNA in evolution (see also RNA world hypothesis ).

Awards (selection)

Web links

Individual evidence

  1. ^ RR Breaker: In Vitro Selection of Catalytic Polynucleotides. In: Chemical Reviews . Volume 97, Number 2, April 1997, pp. 371-390, ISSN  1520-6890 . PMID 11848875 .
  2. ^ Eli Lilly and Company-Elanco Research Award Past Laureates. (No longer available online.) In: asm.org. January 12, 2016, archived from the original on February 1, 2016 ; accessed on February 1, 2016 .
  3. ^ NAS Award in Molecular Biology. In: nasonline.org. Retrieved January 13, 2016 .